MedTech Spectrum

Article Name China

Lishan Biotech Bets on Microbiome Immunotherapy BMC128

BMC128 was developed by Biomica, Evogene’s subsidiary, and is currently completing a Phase 1 clinical study, showing promising early clinical results

06th February, 2026

PHASE Scientific Expands Cervical Health Portfolio with China Distributorship of Liger Medical’s Portable Cervical Treatment

This partnership with Liger Medical reflects our commitment to bringing leading global innovation into China’s healthcare system

05th February, 2026

ZEISS announces NMPA approval in China for powerful ophthalmic microscopes, enhancing surgical visualisation

The ZEISS ARTEVO 750 ophthalmic microscope is another breakthrough in ZEISS's ophthalmic surgical microscope family that made its Chinese debut at the 2025 China International Import Expo (CIIE)

03rd February, 2026

Zylox-Tonbridge to Acquire Germany’s Optimed in Global Expansion Push

Builds an integrated global commercialisation platform to accelerate Zylox-Tonbridge's adoption of innovative vascular solutions worldwide

16th January, 2026

WORK Medical Grants East China Distribution Rights for AI-Automated Blood Cell Morphology Analyzer

The collaboration is expected to accelerate market access and drive large-scale commercialisation of the new product

30th December, 2025

Everest Medicines Announces Commercialisation Service Agreement and License Agreement with Hasten

The two agreements are expected to create significant financial and strategic synergies

15th December, 2025

China Gold Irradiation Introduces IBA’s sustainable X-ray irradiation technology

The Jianxing centre in East China will be the first CGI centre to install X-ray technology

11th December, 2025

Singleron's Matrix NEO Receives Class II Medical Device Approval for Automated Single Cell Analysis

Matrix NEO is the world's first automated single-cell analysis platform to achieve medical device clearance, marking a milestone in bringing single-cell sequencing from research laboratories into clinical practice

17th November, 2025

CoolMPS Brings a New Dimension to Sequencing

The collaboration enables MGI to leverage Swiss Rockets’ strong R&D capabilities and established presence in Europe and the U.S. to commercialise CoolMPS™

10th November, 2025

China Launches Magnetic Resonance Platform for Brain-Computer Interface Research

It enables non-invasive, high-resolution in vivo analysis of the entire brain, significantly improving precision in both space and time

07th November, 2025

Sandstone Easydrip Plus with Hextra Tech Hexagonal Broad Hub Delivers Steadier, More Comfortable Insulin Injections

Pen-needle stability and comfort directly influence user confidence and adherence

03rd November, 2025

Fangzhou’s XingJie LLM Completes Key National Filing, Setting Stage for Further AI-Driven Chronic Care Innovations

The successful filing of the XJ LLM represents a milestone in Fangzhou’s AI-enabled chronic disease management ecosystem

03rd November, 2025

Fangzhou and Fosun Pharma Forge Strategic Alliance to Deliver AI-Powered Psoriasis Management

Through this collaboration, Fangzhou’s AI Health Manager will offer personalised care guidance and monitoring

31st October, 2025

HighTide’s HTD1801 Shows Long-Term Benefits for Type 2 Diabetes in Phase III Studies

The 52-week data from these two Phase III clinical trials demonstrate the durability of response and highlight the comprehensive long-term clinical benefits of HTD1801 in patients with T2DM

31st October, 2025

Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101

This collaboration marks Everest’s strategic expansion into ophthalmology, a high-potential “blue-ocean” therapeutic area

31st October, 2025

MGI Tech announces licensing agreement with Swiss Rockets AG

The strategic partnership is set to fully unlock the patent value and productisation capabilities of CoolMPS, complementing MGI's tried-and-true StandardMPS technology

29th October, 2025

Fangzhou Unveils AI + Weight Management Innovation at China’s Weight Management Symposium in Beijing

China has designated weight management as a national health priority, integrating it into the Healthy China 2030 strategy through a series of government-led initiatives

24th October, 2025